MCNAB JAMES R
Insider CIK 1190126 · CRIS Director · TTNP.OB Director
Trades across companies
| Ticker | Code | Trade | Filed | Shares | Price | Value | Owned after | |
|---|---|---|---|---|---|---|---|---|
| TTNP TITAN PHARMACEUTICALS INC | J Other | 2022-01-28 | 2022-01-28 | 51,021 | — | $0 | 51,021 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2022-01-05 | 2022-01-05 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2021-02-10 | 2021-02-11 | 25,000 | — | $0 | 25,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2018-09-21 | 2018-09-25 | 200,000 | — | $0 | 200,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2018-09-21 | 2018-09-25 | 200,000 | $0.25 | $50.0K | 300,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2017-09-15 | 2017-09-19 | 10,000 | — | $0 | 10,000 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-05 | 2017-05-05 | 16,176 | $1.90 | $30.7K | 50,000 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-05 | 2017-05-05 | 16,176 | $1.90 | $30.7K | 50,000 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-04 | 2017-05-05 | 30,100 | $1.97 | $59.3K | 66,176 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-04 | 2017-05-05 | 30,100 | $1.97 | $59.3K | 66,176 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-03 | 2017-05-05 | 30,000 | $2.18 | $65.4K | 96,276 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-03 | 2017-05-05 | 30,000 | $2.18 | $65.4K | 96,276 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-02 | 2017-05-02 | 35,646 | $2.31 | $82.3K | 126,276 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-05-01 | 2017-05-02 | 38,113 | $2.38 | $90.7K | 161,922 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-28 | 2017-05-02 | 42,949 | $2.45 | $105.2K | 200,035 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-27 | 2017-04-27 | 37,202 | $2.57 | $95.6K | 242,984 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-26 | 2017-04-27 | 32,738 | $2.65 | $86.8K | 879,688 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-26 | 2017-04-27 | 19,814 | $2.65 | $52.5K | 280,186 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-25 | 2017-04-27 | 56,940 | $2.60 | $148.0K | 912,426 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-24 | 2017-04-24 | 42,076 | $2.56 | $107.7K | 1,269,366 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-24 | 2017-04-27 | 42,076 | $2.56 | $107.7K | 969,366 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-21 | 2017-04-24 | 45,705 | $2.58 | $117.9K | 1,311,442 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-21 | 2017-04-27 | 45,705 | $2.58 | $117.9K | 1,011,442 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-20 | 2017-04-24 | 22,541 | $2.66 | $60.0K | 1,357,147 | SEC↗ |
| CRIS CURIS INC | S Sale | 2017-04-20 | 2017-04-27 | 22,541 | $2.66 | $60.0K | 1,057,147 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2017-02-28 | 2017-03-02 | 120,000 | — | $0 | 120,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | A Award deriv | 2017-02-16 | 2017-02-21 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2016-05-31 | 2016-05-31 | 20,000 | $7.03 | $140.6K | 100,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2016-01-19 | 2016-01-21 | 170,000 | — | $0 | 170,000 | SEC↗ |
| TTNP TITAN PHARMACEUTICALS INC | P Buy | 2016-01-13 | 2016-01-14 | 16,363 | $3.16 | $51.7K | 80,000 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | A Award deriv | 2015-12-14 | 2015-12-16 | 10,000 | — | $0 | 10,000 | SEC↗ |
| TTNP.OB TITAN PHARMACEUTICALS INC | A Award deriv | 2015-03-16 | 2015-03-18 | 12,500 | — | $0 | 12,500 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2015-01-26 | 2015-01-28 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CRIS CURIS INC | G Gift | 2014-04-02 | 2014-04-03 | 30,000 | — | $0 | 1,049,688 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2014-01-27 | 2014-01-28 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CRIS CURIS INC | P Buy | 2013-08-16 | 2013-08-19 | 50,000 | $4.00 | $200.0K | 250,000 | SEC↗ |
| CRIS CURIS INC | S Sale | 2013-08-16 | 2013-08-19 | 50,000 | $4.00 | $200.0K | 50,000 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2013-01-17 | 2013-01-18 | 85,000 | — | $0 | 85,000 | SEC↗ |
| CRIS CURIS INC | S Sale | 2012-06-19 | 2012-06-19 | 139,000 | $4.76 | $661.6K | 1,079,688 | SEC↗ |
| CRIS CURIS INC | S Sale | 2012-06-18 | 2012-06-19 | 150,000 | $4.75 | $712.5K | 1,218,688 | SEC↗ |
| CRIS CURIS INC | S Sale | 2012-06-15 | 2012-06-19 | 11,000 | $4.73 | $52.0K | 1,368,688 | SEC↗ |
| CRIS CURIS INC | M Exercise deriv | 2012-01-30 | 2012-02-01 | 85,000 | $2.15 | $182.8K | 0 | SEC↗ |
| CRIS CURIS INC | M Exercise deriv | 2012-01-30 | 2012-02-01 | 85,000 | $2.27 | $192.9K | 0 | SEC↗ |
| CRIS CURIS INC | M Exercise deriv | 2012-01-30 | 2012-02-01 | 87,500 | $2.43 | $212.6K | 0 | SEC↗ |
| CRIS CURIS INC | M Exercise | 2012-01-30 | 2012-02-01 | 85,000 | $2.15 | $182.8K | 0 | SEC↗ |
| CRIS CURIS INC | M Exercise | 2012-01-30 | 2012-02-01 | 87,500 | $2.43 | $212.6K | 0 | SEC↗ |
| CRIS CURIS INC | M Exercise | 2012-01-30 | 2012-02-01 | 85,000 | $2.27 | $192.9K | 1,379,688 | SEC↗ |
| CRIS CURIS INC | A Award deriv | 2012-01-05 | 2012-01-06 | 170,000 | — | $0 | 85,000 | SEC↗ |